T2 Biosystems (TTOO) said Tuesday the Nasdaq Hearings Panel has determined to delist its shares, with trading of the stock to be suspended from Feb. 12.
The company said it does not plan to pursue any further appeal of the ruling after it failed to meet the requirements for bid price and the market value of listed securities.
T2 said its shares are expected to begin trading on the OTC Markets system Wednesday.
Shares of T2 Biosystems were down about 20% in recent trading.
Price: 0.15, Change: -0.04, Percent Change: -20.68
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.